Aurinia Pharmaceuticals Inc.

(AUP:APH)

By |

Profile

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for the patients suffering from serious diseases with high unmet medical need. The firm particularly develops a therapeutic drug to treat autoimmune diseases in particular lupus nephritis. Its main product candidate is Voclosporin.

Contact Information

Website: www.auriniapharma.com
Email: dbourgeault@auriniapharma.com
Main Phone: +1 250 744-2487
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: TSX
CEO: Richard M. Glickman
Employees: 33
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20.94 20.94 20.94 20.94
Low Target Price Estimate 12.8 12.8 12.8 12.8
Mean Target Price Estimate 16.27 16.27 16.27 16.27
Standard Deviation 3.2 3.2 3.2 3.2
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 06/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.41 1.41 1.41